162 related articles for article (PubMed ID: 1425074)
1. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis.
Kishimoto S; Kobayashi H; Shimizu S; Haruma K; Tamaru T; Kajiyama G; Miyoshi A
Dig Dis Sci; 1992 Nov; 37(11):1729-37. PubMed ID: 1425074
[TBL] [Abstract][Full Text] [Related]
2. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
3. Impact of colonic mucosal lipoxin A4 synthesis capacity on healing in rats with dextran sodium sulfate-induced colitis.
Ağış ER; Savaş B; Melli M
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):63-9. PubMed ID: 25908303
[TBL] [Abstract][Full Text] [Related]
4. Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.
Schulte-Bockholt A; Fink JG; Meier DA; Otterson MF; Telford GL; Hopp K; Koch TR
Mol Cell Biochem; 1995 Jan; 142(1):1-7. PubMed ID: 7753037
[TBL] [Abstract][Full Text] [Related]
5. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
6. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
7. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
Koch TR; Michener SR; Carney JA; Go VL
Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
[TBL] [Abstract][Full Text] [Related]
8. Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats.
Björck S; Jennische E; Dahlström A; Ahlman H
Dig Dis Sci; 1997 Apr; 42(4):824-32. PubMed ID: 9125657
[TBL] [Abstract][Full Text] [Related]
9. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
10. Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.
Xu CL; Guo Y; Qiao L; Ma L; Cheng YY
World J Gastroenterol; 2018 Feb; 24(6):706-715. PubMed ID: 29456409
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide.
Koch TR; Carney JA; Go L; Go VL
Gastroenterology; 1988 Feb; 94(2):300-10. PubMed ID: 2446945
[TBL] [Abstract][Full Text] [Related]
12. Intercellular adhesion molecule-1 expression in dextran sodium sulfate-induced colitis in rats.
Breider MA; Eppinger M; Gough A
Vet Pathol; 1997 Nov; 34(6):598-604. PubMed ID: 9396141
[TBL] [Abstract][Full Text] [Related]
13. Role of free radical scavenging activity of vasoactive intestinal peptide in the attenuation of mitochondrial dysfunction to ameliorate dextran sulphate sodium-induced colitis in mice: Implications in ulcerative colitis.
Spoorthi BC; More SS; Gautham SA; Ghosh S; Saha I; Maiti AK
J Dig Dis; 2020 Dec; 21(12):711-723. PubMed ID: 33405317
[TBL] [Abstract][Full Text] [Related]
14. Human neutrophil peptide-1 aggravates dextran sulfate sodium-induced colitis.
Hashimoto S; Uto H; Kanmura S; Sakiyama T; Oku M; Iwashita Y; Ibusuki R; Sasaki F; Ibusuki K; Takami Y; Moriuchi A; Oketani M; Ido A; Tsubouchi H
Inflamm Bowel Dis; 2012 Apr; 18(4):667-75. PubMed ID: 21928371
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
[TBL] [Abstract][Full Text] [Related]
16. Compensatory response of colon tissue to dextran sulfate sodium-induced colitis.
Nakano S; Ohara S; Kubota T; Saigenji K; Hotta K
J Gastroenterol; 1999 Apr; 34(2):207-14. PubMed ID: 10213120
[TBL] [Abstract][Full Text] [Related]
17. Colonic vasoactive intestinal polypeptide in ulcerative colitis.
Surrenti C; Renzi D; Garcea MR; Surrenti E; Salvadori G
J Physiol Paris; 1993; 87(5):307-11. PubMed ID: 8298608
[TBL] [Abstract][Full Text] [Related]
18. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.
Spohn SN; Bianco F; Scott RB; Keenan CM; Linton AA; O'Neill CH; Bonora E; Dicay M; Lavoie B; Wilcox RL; MacNaughton WK; De Giorgio R; Sharkey KA; Mawe GM
Gastroenterology; 2016 Nov; 151(5):933-944.e3. PubMed ID: 27480173
[TBL] [Abstract][Full Text] [Related]
19. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium.
Kitajima S; Takuma S; Morimoto M
Exp Anim; 1999 Jul; 48(3):137-43. PubMed ID: 10480018
[TBL] [Abstract][Full Text] [Related]
20. Defective stimulation of cyclic AMP by prostaglandin E2 in colonic epithelial cells in colitis.
Goldhill J; Zhao L; Xu Y; Donovan V; Burakoff R
Eur J Pharmacol; 1993 Jul; 238(2-3):387-90. PubMed ID: 8405106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
